Ad is loading...
PCITX
Price
$21.49
Change
-$0.19 (-0.88%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

PCITX vs VTSNX

Header iconPCITX vs VTSNX Comparison
Open Charts PCITX vs VTSNXBanner chart's image
Pioneer International Equity C
Price$21.49
Change-$0.19 (-0.88%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
PCITX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCITX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCITX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. PCITX (735M). VTSNX pays higher dividends than PCITX: VTSNX (3.29) vs PCITX (0.56). PCITX was incepted earlier than VTSNX: PCITX (29 years) vs VTSNX (14 years). PCITX is a more actively managed with annual turnover of: 38.00 vs. VTSNX (4.00). PCITX has a lower initial minimum investment than VTSNX: PCITX (1000) vs VTSNX (5000000). PCITX (11.06) and VTSNX (10.92) have marching annual gain over last year. PCITX (16.65) and VTSNX (15.91) have equivalent 5 years return.
PCITXVTSNXPCITX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years14 years-
Gain YTD4.7274.535104%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets735M442B0%
Annual Yield % from dividends0.563.2917%
Returns for 1 year11.0610.92101%
Returns for 3 years-9.36-5.86160%
Returns for 5 years16.6515.91105%
Returns for 10 years18.6329.8162%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals